Name Steward Organization Suggested Domain Suggested Domain Description Cde Group Classification
Anticoagulant agent in hospital type NINDS Treatment
Treatment for all conditions
NIH CDEs
  • NINDS
    • Disease
      • Stroke
        • Classification
          • Supplemental-Highly Recommended
        • Domain
          • Treatment/Intervention Data
            • Drugs
    • Domain
      • Treatment/Intervention Data
        • Drugs
    • Population
      • Adult
      • Pediatric

# Datatype
Value List

# Permissible value Value meaning name Value meaning definition
Direct thrombin inhibitor (Lepirudin, Desirudin, Bivalirudin, Argatroban, Dabigatran) Direct thrombin inhibitor (Lepirudin, Desirudin, Bivalirudin, Argatroban, Dabigatran) Direct thrombin inhibitor (Lepirudin, Desirudin, Bivalirudin, Argatroban, Dabigatran)
Factor Xa inhibitor (Apixaban, Betrixaban, Edoxaban, Rivaroxaban, Fondaparinux) Factor Xa inhibitor (Apixaban, Betrixaban, Edoxaban, Rivaroxaban, Fondaparinux) Factor Xa inhibitor (Apixaban, Betrixaban, Edoxaban, Rivaroxaban, Fondaparinux)
Full dose LMW heparin (Enoxaparin, Others) Full dose LMW heparin (Enoxaparin, Others) Full dose LMW heparin (Enoxaparin, Others)
Other, specify Other, specify Other, specify
Unfractionated heparin IV Unfractionated heparin IV Unfractionated heparin IV
Warfarin (Coumadin) Warfarin (Coumadin) Warfarin (Coumadin)

# Definition
Type(s) of anticoagulant agents received during the acute hospital stay

# Designation
Anticoagulant agent in hospital type

# Identifier Origin Version
C14630 NINDS 3
AnticoagAgentInHospTyp BRICS Variable Name N/A
4Yp8sb9Kp3T NLM CDEs 12-02-2025-download